From the Journals

Trials need standardized reporting of pediatric fever after flu vaccine


 

FROM THE PEDIATRIC INFECTIOUS DISEASE JOURNAL

Dr. Wood reported receiving a fellowship from the National Health and Medical Research Council (NHMRC) and being an investigator for GlaxoSmithKline trials. Dr. Booy reported being an advisor for influenza vaccine manufacturing, an advisory board member, on the speaker’s bureau, and a researcher of vaccines for several manufacturers. The other authors reported no relevant conflicts of interest.

SOURCE: Li-Kim-Moy J et al. Pediatr Infect Dis J. 2018 Oct;37(10):971-5.

Pages

Recommended Reading

DTPa-HBV-IPV/Hib in infancy maintains lasting immune memory against HBV in teens
MDedge Infectious Disease
Study supports meningococcal B vaccine in children with rare diseases
MDedge Infectious Disease
ACP roadmap to raise adult immunization rates
MDedge Infectious Disease
No increase in autism risk with prenatal Tdap
MDedge Infectious Disease
French warn of upsurge in pneumococcal meningitis
MDedge Infectious Disease
Zika virus vaccine trial launches
MDedge Infectious Disease
Russian Twitter bots and trolls amplify vaccine controversy
MDedge Infectious Disease
Live attenuated flu vaccine gets ACIP nod for 2018-2019 season
MDedge Infectious Disease
Recommending HPV vaccination: How would you grade yourself?
MDedge Infectious Disease
ID experts urge widespread flu vaccination for 2018-2019 season
MDedge Infectious Disease